LAW FIRM EXTRACTS NEW HIGHER OFFER FOR OBAGI SHAREHOLDERS
The law firm Tripp Levy PLLC is pleased to announce that Merz Pharma has made a $22 per share offer to acquire OMPI. This proposal is believed to be superior to the VRX offer, which is at $19.75 per share.
If you are a shareholder and are part of our lawsuit you may be eligible for this higher offer. If not, please contact us toll free at 1-877-772-3975 or email at contact @ tripplevy